News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
C. Jillian Tsai: Phase II Study of Pembrolizumab and Chemoradiation in Head and Neck Cancer
C. Jillian Tsai/X
May 30, 2025, 05:52

C. Jillian Tsai: Phase II Study of Pembrolizumab and Chemoradiation in Head and Neck Cancer

C. Jillian Tsai, Lead of Palliative Radiotherapy and Oligometastases Program (PROP) at Princess Margaret Cancer Centre, posted on X:

“Remarkable efforts to obtain on-treatment tissue to study TME.
CRT with sequential pembro *might* be more favorable than concurrent pembro.”

Ttile: Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer

Authors: Dan P. Zandberg, Lazar Vujanovic, David A. Clump, Brian P. Isett, Hong Wang, Gabriel Sica, Riyue Bao, Housayin Li, James Ohr, Heath D. Skinner, Raja R. Seethala, Simion I. Chiosea, Robert L. Ferris, Julie E. Bauman

Read The Full Article at Journal of Clinical Oncology.

C. Jillian Tsai: Phase II Study of Pembrolizumab and Chemoradiation in Head and Neck Cancer

More posts featuring Head and Neck Cancer.

Brian P. Isett C. Jillian Tsai cancer Dan P. Zandberg David A. Clump Gabriel Sica Heath D. Skinner Hong Wang Housayin Li James Ohr Julie E. Bauman Lazar Vujanovic OncoDaily Oncology Raja R. Seethala Riyue Bao Robert L. Ferris Simion I. Chiosea
Special Coverage
Blog
Jul 10, 2025, 15:01
DPD Deficiency and Why It’s Important in Colorectal Cancer Treatment - Global Colon Cancer Association
Blog
Jul 10, 2025, 14:59
Bo Wang: How Recent Advances in Foundation Models Are Redefining What’s Possible in Cancer Diagnostics
Blog
Jul 10, 2025, 14:51
Screening Recommendations For Common Cancers - Asian Fund for Cancer Research
Societies
Jul 10, 2025, 14:47
Registration is Open for the ESMO Asia Congress 2025
Blog
Jul 10, 2025, 14:45
Leukemia and Breast Cancer Patient Leveraged Her Social Media Savvy to Navigate the Most Difficult Journey of Her Life - City of Hope
Blog
Jul 10, 2025, 14:36
Mladen Marinkovic: 'Clinical Oncology with Radiotherapy' is Offering a Comprehensive and Practical Overview of Oncology
Blog
Jul 10, 2025, 14:35
Agenus Thanks ESMO and Ben Schlechter for Sharing the New Data of BOT/BAL in Refractory MSS CRC
Science
Jul 10, 2025, 14:26
Myeloma Paper of the Day, July 10th, Suggested by Robert Orlowski
Blog
Jul 10, 2025, 14:16
Voice of the Families, Post 36 Ninsimma and Her Mother - CANCaRe Africa
Career
Jul 10, 2025, 14:15
Leadership Transition: Brad Cairns to Lead Huntsman Cancer Institute After Mary Beckerle’s Tenure
Blog
Jul 10, 2025, 14:01
Eugene Woods: Advocate Health Expands Rural Commitment with $100M Investment in Yadkin Valley
Blog
Jul 10, 2025, 13:53
Ulrika Årehed Kågström Calls on the Cancer Community to Help Make the Second Half of 2025 Count - UICC